Cargando…
CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway
The mammalian target of rapamycin (mTOR) is a potentially important therapeutic target in a broad range of cancer types. mTOR inhibitors such as rapamycin and its analogs (rapalogs) have been proven effective as anticancer agents in non-small cell lung cancer (NSCLC), whereas they strongly enhance p...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053688/ https://www.ncbi.nlm.nih.gov/pubmed/27050281 http://dx.doi.org/10.18632/oncotarget.8497 |
_version_ | 1782458462236573696 |
---|---|
author | Wen, Qiuyuan Wang, Weiyuan Luo, Jiadi Chu, Shuzhou Chen, Lingjiao Xu, Lina Zang, Hongjing Alnemah, Mohannad Ma Ma, Jian Fan, Songqing |
author_facet | Wen, Qiuyuan Wang, Weiyuan Luo, Jiadi Chu, Shuzhou Chen, Lingjiao Xu, Lina Zang, Hongjing Alnemah, Mohannad Ma Ma, Jian Fan, Songqing |
author_sort | Wen, Qiuyuan |
collection | PubMed |
description | The mammalian target of rapamycin (mTOR) is a potentially important therapeutic target in a broad range of cancer types. mTOR inhibitors such as rapamycin and its analogs (rapalogs) have been proven effective as anticancer agents in non-small cell lung cancer (NSCLC), whereas they strongly enhance phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) and activation of Akt, which cause resistance to mTOR-targeted therapy after an initial response. Rapamycin induces eIF4E phosphorylation by activating MAPK-interacting kinases (Mnks), and therefore targeting Mnk/eIF4E pathway represents a potential therapeutic strategy for the treatment of NSCLC. Here, our results showed that over-expression of p-Mnk1 and p-eIF4E was significantly associated with poor overall survival of NSCLC patients and high expression of p-Mnk1 might act as an independent prognostic biomarker for these patients. Meanwhile, inhibiting Mnk1 expression by Mnk inhibitor (CGP57380) could abrogate rapalogs (RAD001)-induced eIF4E phosphorylation and Akt activation. Furthermore, combination of CGP57380 and RAD001 could induce NSCLC cells apoptosis via activating intrinsic mitochondrial pathway, and exert synergistic antitumor efficacy both in vitro and in vivo. In conclusion, combination of targeting both mTOR and Mnk/eIF4E signaling pathways to enhance effectiveness of mTOR-targeted cancer therapy might be significant innovation for the personalized treatment of NSCLC. |
format | Online Article Text |
id | pubmed-5053688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-50536882016-10-12 CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway Wen, Qiuyuan Wang, Weiyuan Luo, Jiadi Chu, Shuzhou Chen, Lingjiao Xu, Lina Zang, Hongjing Alnemah, Mohannad Ma Ma, Jian Fan, Songqing Oncotarget Research Paper The mammalian target of rapamycin (mTOR) is a potentially important therapeutic target in a broad range of cancer types. mTOR inhibitors such as rapamycin and its analogs (rapalogs) have been proven effective as anticancer agents in non-small cell lung cancer (NSCLC), whereas they strongly enhance phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) and activation of Akt, which cause resistance to mTOR-targeted therapy after an initial response. Rapamycin induces eIF4E phosphorylation by activating MAPK-interacting kinases (Mnks), and therefore targeting Mnk/eIF4E pathway represents a potential therapeutic strategy for the treatment of NSCLC. Here, our results showed that over-expression of p-Mnk1 and p-eIF4E was significantly associated with poor overall survival of NSCLC patients and high expression of p-Mnk1 might act as an independent prognostic biomarker for these patients. Meanwhile, inhibiting Mnk1 expression by Mnk inhibitor (CGP57380) could abrogate rapalogs (RAD001)-induced eIF4E phosphorylation and Akt activation. Furthermore, combination of CGP57380 and RAD001 could induce NSCLC cells apoptosis via activating intrinsic mitochondrial pathway, and exert synergistic antitumor efficacy both in vitro and in vivo. In conclusion, combination of targeting both mTOR and Mnk/eIF4E signaling pathways to enhance effectiveness of mTOR-targeted cancer therapy might be significant innovation for the personalized treatment of NSCLC. Impact Journals LLC 2016-03-30 /pmc/articles/PMC5053688/ /pubmed/27050281 http://dx.doi.org/10.18632/oncotarget.8497 Text en Copyright: © 2016 Wen et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Wen, Qiuyuan Wang, Weiyuan Luo, Jiadi Chu, Shuzhou Chen, Lingjiao Xu, Lina Zang, Hongjing Alnemah, Mohannad Ma Ma, Jian Fan, Songqing CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway |
title | CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway |
title_full | CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway |
title_fullStr | CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway |
title_full_unstemmed | CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway |
title_short | CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway |
title_sort | cgp57380 enhances efficacy of rad001 in non-small cell lung cancer through abrogating mtor inhibition-induced phosphorylation of eif4e and activating mitochondrial apoptotic pathway |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053688/ https://www.ncbi.nlm.nih.gov/pubmed/27050281 http://dx.doi.org/10.18632/oncotarget.8497 |
work_keys_str_mv | AT wenqiuyuan cgp57380enhancesefficacyofrad001innonsmallcelllungcancerthroughabrogatingmtorinhibitioninducedphosphorylationofeif4eandactivatingmitochondrialapoptoticpathway AT wangweiyuan cgp57380enhancesefficacyofrad001innonsmallcelllungcancerthroughabrogatingmtorinhibitioninducedphosphorylationofeif4eandactivatingmitochondrialapoptoticpathway AT luojiadi cgp57380enhancesefficacyofrad001innonsmallcelllungcancerthroughabrogatingmtorinhibitioninducedphosphorylationofeif4eandactivatingmitochondrialapoptoticpathway AT chushuzhou cgp57380enhancesefficacyofrad001innonsmallcelllungcancerthroughabrogatingmtorinhibitioninducedphosphorylationofeif4eandactivatingmitochondrialapoptoticpathway AT chenlingjiao cgp57380enhancesefficacyofrad001innonsmallcelllungcancerthroughabrogatingmtorinhibitioninducedphosphorylationofeif4eandactivatingmitochondrialapoptoticpathway AT xulina cgp57380enhancesefficacyofrad001innonsmallcelllungcancerthroughabrogatingmtorinhibitioninducedphosphorylationofeif4eandactivatingmitochondrialapoptoticpathway AT zanghongjing cgp57380enhancesefficacyofrad001innonsmallcelllungcancerthroughabrogatingmtorinhibitioninducedphosphorylationofeif4eandactivatingmitochondrialapoptoticpathway AT alnemahmohannadma cgp57380enhancesefficacyofrad001innonsmallcelllungcancerthroughabrogatingmtorinhibitioninducedphosphorylationofeif4eandactivatingmitochondrialapoptoticpathway AT majian cgp57380enhancesefficacyofrad001innonsmallcelllungcancerthroughabrogatingmtorinhibitioninducedphosphorylationofeif4eandactivatingmitochondrialapoptoticpathway AT fansongqing cgp57380enhancesefficacyofrad001innonsmallcelllungcancerthroughabrogatingmtorinhibitioninducedphosphorylationofeif4eandactivatingmitochondrialapoptoticpathway |